Q1 Net Income Surges to $6.5M from Asset Sales, Debt Reduced by $9M, But Going Concern Remains
GBCS has more than doubled off its 52-week low of $0.405 on elevated volume (2.0× avg).
Summary
Selectis Health reported a $6.5 million net income for Q1 2026, driven by asset sales that also reduced debt by $9 million and turned equity positive, despite a 32% revenue decline and persistent going concern warnings.
Key Events · Earnings and Guidance · GBCS
-
Significant Net Income Driven by Asset Sales
The company reported a net income of $6.53 million for the three months ended March 31, 2026, a substantial improvement from a net loss of $0.66 million in the prior year, primarily due to an $8.9 million gain on the sale of assets.
-
Balance Sheet Strengthened by Debt Reduction
Total debt, net of discount, decreased by $8.61 million from $31.00 million at December 31, 2025, to $22.39 million at March 31, 2026. Stockholders' equity shifted from a $6.21 million deficit to a positive $0.26 million.
-
Operational Revenue Decline and Worsening Operating Loss
Healthcare revenue decreased by 32% to $7.18 million for Q1 2026 compared to $10.49 million in Q1 2025, attributed to facility sales. The loss from operations widened to $1.26 million from $0.42 million in the prior year.
-
Ongoing Going Concern and Material Weakness
Management continues to report substantial doubt about the company's ability to continue as a going concern and disclosed an ongoing material weakness in internal controls related to the lack of a formal review process.
Analysis · GBCS · Real Estate & Construction
Selectis Health reported a significant net income for Q1 2026, primarily driven by the sale of two Georgia facilities. This, along with further asset sales disclosed as a subsequent event, has substantially reduced total debt and moved the company's equity from a deficit to a positive balance. However, the underlying operational revenue declined by 32%, and the operating loss worsened. The company continues to face substantial doubt about its ability to continue as a going concern and has an unresolved material weakness in internal controls. This filing details the financial impact of the company's ongoing restructuring efforts to improve liquidity and reduce debt by divesting assets.
At the time of this filing, GBCS was trading at $2.97 on OTC in the Real Estate & Construction sector, with a market capitalization of approximately $9.1M. The 52-week trading range was $0.41 to $6.25. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.